BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7977175)

  • 1. A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in complete responders following VAPE induction and late intensification.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Donnelly EJ; Raub WA
    Am J Clin Oncol; 1994 Dec; 17(6):527-37. PubMed ID: 7977175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II clinical trial evaluating the use of two sequential, four-drug combination chemotherapy regimens in ambulatory bronchogenic adenocarcinoma patients.
    Broder LE; Sridhar KS; Selawry OS; Charyulu KN; Rao RK; Saldana MJ; Lenz C
    Am J Clin Oncol; 1992 Dec; 15(6):480-6. PubMed ID: 1449109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell lung cancer: a phase III study of the Eastern Cooperative Oncology Group.
    Ettinger DS; Finkelstein DM; Abeloff MD; Ruckdeschel JC; Aisner SC; Eggleston JC
    J Clin Oncol; 1990 Feb; 8(2):230-40. PubMed ID: 2153765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Bacchi M; Hürny C; Bernhard J; Cerny T; Martinelli G; Leyvraz S; Senn HJ; Stahel R; Siegenthaler P
    Ann Oncol; 1995 Feb; 6(2):157-66. PubMed ID: 7786823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cohen MH; Ihde DC; Bunn PA; Fossieck BE; Matthews MJ; Shackney SE; Johnston-Early A; Makuch R; Minna JD
    Cancer Treat Rep; 1979 Feb; 63(2):163-70. PubMed ID: 221114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.
    Havemann K; Wolf M; Holle R; Gropp C; Drings P; Manke HG; Hans K; Schroeder M; Heim M; Victor N
    Cancer; 1987 Mar; 59(6):1072-82. PubMed ID: 3028596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Aisner J; Whitacre M; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Feb; 66(2):221-30. PubMed ID: 6275987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Alberto P; Bleher EA; Ludwig C; Siegenthaler P; Martinelli G; Sauter C; Schatzmann E; Senn HJ
    Ann Oncol; 1994 Dec; 5(10):921-8. PubMed ID: 7696164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.
    Chahinian AP; Propert KJ; Ware JH; Zimmer B; Perry MC; Hirsh V; Skarin A; Kopel S; Holland JF; Comis RL
    J Clin Oncol; 1989 Aug; 7(8):993-1002. PubMed ID: 2547030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).
    Joss RA; Alberto P; Hürny C; Bacchi M; Leyvraz S; Thürlimann B; Cerny T; Martinelli G; Stahel R; Ludwig C
    Ann Oncol; 1995 Jan; 6(1):41-8. PubMed ID: 7536028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of small-cell carcinoma of lung: a randomized comparison of alternating and sequential combination chemotherapy programs.
    Daniels JR; Chak LY; Sikic BI; Lockbaum P; Kohler M; Carter SK; Reynolds R; Bohnen R; Gandara D; Yu J
    J Clin Oncol; 1984 Nov; 2(11):1192-9. PubMed ID: 6092554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer.
    Tummarello D; Guidi F; Torresi U; Isidori P; Rossi A; Dazzi C; Cellerino R
    Acta Oncol; 1990; 29(4):417-20. PubMed ID: 2167701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    Valdivieso M; Cabanillas F; Keating M; Barkley HT; Murphy WK; Burgess MA; Frazier H; Chen T; Bodey GP
    Am J Med; 1984 Mar; 76(3):405-12. PubMed ID: 6322584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
    Navarro M; Mur E; Jolis L; Bellmunt J; Bodi R; Solé LA; Rubio D
    Rev Clin Esp; 1991 Oct; 189(5):209-12. PubMed ID: 1666192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antineoplastic chemotherapy for bronchial carcinoma].
    Tanneberger S
    Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current chemotherapy of small cell lung cancer.
    Livingston RB
    Chest; 1986 Apr; 89(4 Suppl):258S-263S. PubMed ID: 3007042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Ohnoshi T; Hiraki S; Ueoka H; Kawahara S; Numata T; Nishii K; Yonei T; Yamashta H; Kiura K; Kozuka A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1341-8. PubMed ID: 2543304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive alternating chemotherapy regimen in small cell carcinoma of the lung.
    Markman M; Abeloff MD; Berkman AW; Waterfield WC
    Cancer Treat Rep; 1985 Feb; 69(2):161-6. PubMed ID: 2982490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.